{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T06:09:08Z","timestamp":1649138948019},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.31003\/uspnf_m23310_02_01","type":"standard","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:18:31Z","timestamp":1629123511000},"source":"Crossref","is-referenced-by-count":0,"title":["Dexamethasone Elixir"],"prefix":"10.31003","member":"14819","container-title":[],"original-title":[],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T15:47:17Z","timestamp":1629128837000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M23310_02_01.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m23310_02_01","relation":{},"subject":[]}}